Arvinas, Inc. (NASDAQ: ARVN) has announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug ...

QuantumScape has logged a -27.6% 52 week change, compared to 11.1% for the S&P 500 QS has an average analyst rating of hold ...

Large-cap Consumer Staples company Sony has moved 1.2% so far today on a volume of 1,552,801, compared to its average of ...

Legend Biotech trades -54.53% away from its average analyst target price of $76.42 per share. The 21 analysts following the ...

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States ...

AVGO has reported YOY quarterly earnings growth of 188.1% and gross profit margins of 0.8% The company's free cash flow for ...

We're taking a closer look at Verona Pharma today, as the chatter surrounding the stock has increased notably in the last few ...

ANET has an average analyst rating of buy and is -8.09% away from its mean target price of $106.0 per share Its trailing ...

Does this mean the stock will reverse course? Analysts are giving XPEV an average rating of buy and target prices ranging ...

Robinhood Markets is part of the Finance sector, which has an average P/E ratio of 15.92 and an average P/B of 1.78 HOOD has ...

Besides an analyst consensus of strong upside potential, other market factors point to there being mixed market sentiment on Summit Therapeutics. The above analysis is intended for educational ...

For Monster Beverage, average sales revenue over the last 5 years has been $9.65 Billion, so in the context of the Graham ...